The following review aims to examine the available evidence to guide best practice in preventing ovarian hyperstimulation syndrome (OHSS). As it stands, there is no single method to completely prevent OHSS. There seems to be a benefit, however, in categorizing women based on their risk of OHSS and individualizing treatments to curtail their chances of developing the syndrome. At present, both A...

Correspondence to: Lavinia Bran. Tel. 0745091202, E-mail: [email protected], The University Clinic of Obstetric Gynecology “Bega” ,Timisoara str. V. Babes nr. 12 jud. Timis SUMMARY: The ovarian hyperstimulation syndrome (OHSS) is produced by the exaggerated action of the gonadotropic hormones used for ovulation induction in case of in vitro fertilization, currently being considered an iatro...

BACKGROUND The aim of this study was to determine the relationship between a purported luteinizing hormone/chorionic gonadotropin (LHCGR) high function polymorphism (rs4539842/insLQ) and outcome to controlled ovarian hyperstimulation (COH). METHODS This was a prospective study of 172 patients undergoing COH at the Fertility and IVF Center at GWU. DNA was isolated from blood samples and a regi...

The case of an arterial aorto-subclavian thromboembolism associated with a moderate ovarian hyperstimulation syndrome (OHSS) and following ovulation induction for in-vitro fertilization in a young woman is reported. Because of the lack of response to systemic thrombolysis, a left postero-lateral thoracotomy was performed on day 8 after embryo transfer. A fibrinocruoric embolus situated at the j...

the objective of this study was to examine the correlation between both midfollicular fsh/lh ratio and number(s) of follicles with ovarian hyperstimulation syndrome (ohss) in patients with polycystic ovarian syndrome (pcos). this was carried out in ivf unit at mirza kouchak khan hospital. to induce ovulation, pcos patients were stimulated with gonadotropines. fifty four pcos patients with norma...

objective: the study assessed the efficacy of low dose ketoconazole in addition to clomiphene citrate ( cc) and hmg on ovulation induction. materials and methods: a double blind, randomized, clinical trial was performed on fifty infertile patients with pcos who had failed to respond to a daily dose of hmg and 100 mg cc for controlled ovarian hyperstimulation in vali-e-asr reproductive health re...

background: evaluation of anti-mullerian hormone (amh) cut-off levels in assisted reproductive technology (art) as predictive factor for individualization of stimulation protocols and to avoid ovarian hyperstimulation syndrome (ohss). materials and methods: in a retrospective study, 177 infertile patients were assessed for amh in serum and follicular fluid (ff) on the day of follicular puncture...

Background: To explore possible predictors of severe late ovarian hyperstimulation syndrome (SL-OHSS) in fresh embryo transfer cycles. Methods: We conducted a historical cohort study Chinese tertiary hospital from January 2017 to December 2019, with total 6931 women who had the first included. SL-OHSS was defined as symptoms OHSS occurring 12–17 days after ovulation triggering. Possible determi...

Background: Infertility is becoming global health issue, which affects multiple aspects of human life in both genders . Medical induction ovulation with clomiphene citrate has been first line treatment infertility since 1962 Discrepancy rate and pregnancy along complication most the infertile patients raises question for alternative Increased risk (OHSS) ovarian hyperstimulation syndrome associ...

Ovarian hyperstimulation syndrome (OHSS) is a serious complication of assisted reproduction techniques using in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI). Its etiology has still not yet been fully resolved. Human chorionic gonadotrophin, administered exogenously as well as produced endogenously during pregnancy, is responsible for the onset of OHSS, and high levels of ...